Unraveling rhabdomyosarcoma, osteosarcoma, dipg and medulloblastoma using engineering, biomedical, and translational research tools.
Monday, February 4, 2013
Dupont creates new opportunities
The recent change in policy by Dupont with regard to the Oncomouse patent opens the door to academic-pharma collaboration. It may also be possible to streamline development of novel drug testing by creating a non-profit company or organization for this specific purpose. Rhabdomyosarcoma, Inc? Would members of the community have interest in such an endeavor?
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment